Cleared Special

K123452 - TRACKER-17 MICROCATHER

K123452 is the FDA 510(k) clearance for TRACKER-17 MICROCATHER by Stryker. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Special 510(k) pathway after a 56-day FDA review.

K123452 · Stryker · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2013
Decision
56d
Days
Class 2
Risk

K123452 is an FDA 510(k) clearance for the TRACKER-17 MICROCATHER, 150 CM LONG AND 15.0 CM FLEXIBLE DISTAL SHAFT, TRACKE.... Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Stryker (Fremont, US). The FDA issued a Cleared decision on January 3, 2013 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Stryker devices

Submission Details

510(k) Number K123452 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 2012
Decision Date January 03, 2013
Days to Decision 56 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
69d faster than avg
Panel avg: 125d · This submission: 56d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 491
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K123452.
CPS DIRECT UNIVERSAL SLITTABLE OUTER CATHETER
K130257 · St Jude Medical · Mar 2013
ADVANCE MICRO 14 ULTRA LOW PROFILE BALLOON DILATATION CATHETER MODEL PTA3
K122940 · Cook, Inc. · Mar 2013
SELECTRA 7F CATHETERS
K123324 · Biotronik, Inc. · Jan 2013
PENUMBRA DDC CATHETERS
K122772 · Penumbra, Inc. · Nov 2012
ATTAIN CLARITY 6225 VENOGRAM BALLOON CATHETER
K121219 · Medtronic, Inc. · Sep 2012
RUBICON 18 SUPPORT CATHETER
K122394 · Boston Scientific Corp · Aug 2012